The largest database of trusted experimental protocols

4 protocols using primary antibody against gapdh

1

Quantitative Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein from cell lines was extracted using a whole-cell extraction buffer. Protein samples were separated by SDS-PAGE and transferred to polyvinylidene fluoride membranes (Millipore Corporation, Bedford, MA, USA). After blocking, the membranes were incubated overnight at 4°C with the following primary antibodies: HtrA2 (1 : 1000) and GAPDH (1 : 2500). Primary antibody against HtrA2 was purchased from ZEN BIO, China. The primary antibody against GAPDH was purchased from Abcam, Cambridge, UK. Subsequently, the membranes were developed with secondary peroxidase-coupled anti-rabbit antibodies, followed by chemiluminescence imaging. Band intensity was quantified using ImageJ software.
+ Open protocol
+ Expand
2

DEN Modulates Inflammatory Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
DEN (molecular formula: C16H25NO2, MW: 263.19, and CAS No. 2115-91-5) was purchased from Chengdu Pufei De Biotechnology Co., Ltd. (Chengdu, China). Recombinant human IL-1β was purchased from PeproTech (Cranbury, NJ, USA). CCK-8 was obtained from Dojindo (Kumamoto, Japan). The cell culture reagents were purchased from Gibco (Grand Island, NY, USA). The primary antibody against GAPDH was obtained from Abcam (Cambridge, MA, USA). The primary antibodies against Col2a1, p21, and ACAN were obtained from Abcolonal (Wuhan, China). The primary antibodies against TNF-α, MMP13, ADAMTS5, p65, β-Actin, and p16INK4a were purchased from Proteintech (Wuhan, China). The primary antibodies against IL-6, IκB-α, and Lamin B were purchased from Abmart (Shanghai, China).
+ Open protocol
+ Expand
3

Western Blot Analysis of Cell Cycle Regulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liver tissues or cells were lysed in RIPA buffer with complete protease inhibitor (Sigma). Nucleoprotein was prepared as previously described (Ho et al., 2010 (link)). Then whole lysates (30 μg) were separated by polyacrylamide gel electrophoresis and proteins were transferred to polyvinylidene difluoride (PVDF) membranes. These membranes were incubated with primary antibodies against BUB3 (1:2,000, CY8528), CHK1 (1:1,000, CY5063), cyclin A (1:1,000, CY1026), MCM5 (1:2,000, CY7185), P21 (1:1,000, 27296-1-AP), Ube2c (1:1,000, 12134-2-AP), and GAPDH (1:2,000, ab9485) overnight at 4°C followed by incubate with secondary antibodies [goat anti-rabbit secondary antibody (HRP)] 2 h at room temperature. Immune complexes were detected using the Enhanced Chemiluminescence System (Thermo Fisher Scientific) and the intensity of each band was quantified using ImageJ software. Primary antibodies against Bub3, CHK1, cyclin A, and MCM5 were purchased from Abways (Shanghai, China). Primary antibodies against P21 and Ube2c were purchased from Proteintech (Wuhan, Hubei, China). Primary antibody against GAPDH was purchased from Abcam (Shanghai, China).
+ Open protocol
+ Expand
4

STAT3 and c-Myc Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies against STAT3, pY705 STAT3, and c-Myc were purchased from Cell Signaling Technology (Cambridge, MA, USA). Primary antibody against GAPDH was purchased from Abcam (Cambridge, MA, USA). HRP-conjugated anti-mouse IgG and anti-rabbit IgG and streptavidin-HRP conjugate were obtained from GE Healthcare Bio-Sciences (Piscataway, NJ, USA). BENDA, HP2, and BM1EE were provided by SymBio Pharmaceuticals Limited (Minato-ku, Tokyo, Japan). Peptides were synthesized by NippiBiomatrix Laboratory (Adachi-ku, Tokyo, Japan). Anti-5-carboxyfluorescein (FITC) acceptor beads and streptavidin-coated donor beads were purchased from PerkinElmer Life Sciences (Waltham, MA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!